User login

Enter your username and password here in order to log in on the website:
Login

Forgot your password?

Please note: While some information will still be current in a year, other information may already be out of date in three months time. If you are in any doubt, please feel free to ask.

Lungs or pancreas - clinical trials

Question
Is there anything for the mutations ending in ...X. When will it be available in Greece? Does it concern the lungs or the pancreas. Thank you!
Answer
Dear friend,
We do not know when the clinical trials of the drug about the ....X mutations, that are carried out presently in the USA and Europe, will be finished. When they are successfully completed, the drug will receive approval for commercial distribution. The drug being tested is about the lungs.

Yours friendly,
Dr. Stavros Doudounakis
18.02.2011
18.2.11
The question aims at the new drug PTC124 which is tested in clinical trials at the moment, aiming at "stop-mutations" ending with X.
Please find additional information in the Q/A "Mutation F508del/E822X" which was asked on the Greek platform.
D. d'Alquen